Pso­ri­a­sis and pso­ri­at­ic arthri­tis drugs criss­cross cat­e­gories, but derm and rheum docs split on pref­er­ences

As drugs in pso­ri­a­sis and pso­ri­at­ic arthri­tis ther­a­py ar­eas nab new in­di­ca­tions that criss­cross the two cat­e­gories, der­ma­tol­o­gists and rheuma­tol­o­gists are as­sess­ing their op­tions. The …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA